Injectable BPC-157 is preferred for musculoskeletal injuries, as it allows targeted delivery to the affected area and higher systemic bioavailability
The Power of Combination: The S-LiTE Trial Research published in JAMA Network Open (Sandsdal et al., 2023) and The Lancet Healthy Longevity (Jensen et al., 2026) compared GLP-1 use alone versus GLP-1 plus exercise: Body Composition: The "Exercise + GLP-1" group reduced abdominal fat by 6.1% , nearly double the results of the medication-only group
A study shows that when used with lifestyle changes, the weekly 2.4 mg dose of semaglutide reduced 10-15% of body weight compared to the placebo, which reduced body weight by only 2-3%
The Power of Peptides They reduce inflammation, stimulate repair, and support kidney function at a cellular level
Semaglutide does not selectively remove abdominal fat
This data is invaluable for your doctor